Mark Newman

Mark Newman is a declared insider at 2 companies (chief executive); the most frequent names are Chemours Co and Altria Group, Inc. In total, 15 filings cover trades dated from 1 September 2015 to 9 June 2023.

Market trades split into 2 purchases (€478k) and 1 sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants and 4 option exercises. Since January 2023: 2 purchases and no sales on the market.

Most recently, on 12 June 2023, the filings show an open-market purchase worth €232k in Chemours Co. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.